Patent · US Expired

Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof

US6258817A · kind A · utility

1Cited by
9References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2000
Grant dateJul 10, 2001
Priority date
Expiry dateFeb 15, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns pharmaceutically useful compounds of the formula I, in which A.sup.1, A.sup.2, A.sup.3, A.sup.4, B.sup.1, m, Ar, W, X, Y, Z and R.sup.1 have any of the meanings defined herein, and their pharmaceutically acceptable salts, and pharmaceutical compositions containing them. The novel compounds possess endothelin receptor antagonist activity and are useful, for example, in the treatment of diseases or medical conditions in which elevated or abnormal levels of endothelin play a significant causative role. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.